Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.

Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Kalsi JK, Singh N, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Parmar M, Jacobs IJ, UKCTOCS team.

Open source

DOI: 10.3310/bhbr5832
Published: 2025-05-01
Container: Health Technol Assess
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3310/bhbr5832,
  title = {Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.},
  author = {Menon U and  Gentry-Maharaj A and  Burnell M and  Ryan A and  Kalsi JK and  Singh N and  Dawnay A and  Fallowfield L and  McGuire AJ and  Campbell S and  Skates SJ and  Parmar M and  Jacobs IJ and  UKCTOCS team.},
  year = {2025},
  journal = {Health Technol Assess},
  doi = {10.3310/bhbr5832},
  url = {https://doi.org/10.3310/bhbr5832}
}

RIS

TY  - JOUR
TI  - Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
AU  - Menon U
AU  -  Gentry-Maharaj A
AU  -  Burnell M
AU  -  Ryan A
AU  -  Kalsi JK
AU  -  Singh N
AU  -  Dawnay A
AU  -  Fallowfield L
AU  -  McGuire AJ
AU  -  Campbell S
AU  -  Skates SJ
AU  -  Parmar M
AU  -  Jacobs IJ
AU  -  UKCTOCS team.
PY  - 2025
JO  - Health Technol Assess
DO  - 10.3310/bhbr5832
UR  - https://doi.org/10.3310/bhbr5832
ER  -

APA

U, M., A, G., M, B., A, R., JK, K., N, S., A, D., L, F., AJ, M., S, C., SJ, S., M, P., IJ, J., & team., U. (2025). Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.. Health Technol Assess. https://doi.org/10.3310/bhbr5832

Source records

europe-pmc · retrieved 2026-09-25T22:38:44.307Z